| Date |
Research Question / Title |
Unique ID |
Research Team |
|
April 6, 2021
|
How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals
|
CC210301 RR
|
Critical Care
|
|
May 2022
|
Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR)
|
EOC220301 SBAR
|
EOC
|
|
May 19, 2020
|
Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19
|
EPM050901 RR Table
|
Epidemiology & Modelling
|
|
June 10, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 RR
|
EOC
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
|
January 22, 2021
|
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
|
EOC062201v2 RR
|
EOC
|
|
January 22, 2021
|
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
|
EOC062201v2 RR Table
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
February 10, 2022
|
What are the latest health policy definitions of being fully vaccinated?
|
EOC220101 RR Table
|
EOC
|
|
February 10, 2022
|
What are the latest health policy definitions of being fully vaccinated?
|
EOC220101 RR
|
EOC
|
|
February 18, 2022
|
What are the one year outcomes for ICU COVID patients?
|
EOC220201 RR Table
|
EOC
|
|
February 18, 2022
|
What are the one year outcomes for ICU COVID patients?
|
EOC220201 RR
|
EOC
|
|
January 13, 2021
|
What are the outcomes of ECMO and COVID, particularly in small centers?
|
EOC011101 RR
|
EOC
|
|
December 9, 2020
|
What are the predictors of mortality in hospitalized COVID-19 patients?
|
CC120402 RR
|
Critical Care
|
|
May 19, 2020
|
What are the risk factors for severity and death associated with COVID-19?
|
EPM050901 RR
|
Epidemiology & Modelling
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR Table
|
EOC
|
|
March 12, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401 RR
|
Public Health
|
|
January 15, 2021
|
What evidence is available to inform vaccination planning in congregate living?
|
EOC011102 RR
|
EOC
|
|
June 6, 2022
|
What is known about hybrid immunity to COVID-19?
|
INF220501 RR Table
|
Infectious Disease
|
